Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206.

By B. Rini, S. Halabi, J. Rosenberg, W. Stadler, D. Vaena, L. Archer, J. Atkins, J. Picus, P. Czaykowski, J. Dutcher and 1 more. Journal of Clinical Oncology, 2010

778 citations recorded by the source corpus.

Subfields: Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/2aa090c0f9ce7bd95cf41ed481dc4734efcd10a8